Scarica l'app Stockscreener
128.39
2.29%
2.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$125.46
Aprire:
$125.72
Volume 24 ore:
4.74M
Relative Volume:
0.77
Capitalizzazione di mercato:
$223.28B
Reddito:
$43.84B
Utile/perdita netta:
$13.90B
Rapporto P/E:
16.10
EPS:
7.9725
Flusso di cassa netto:
$6.92B
1 W Prestazione:
+5.11%
1M Prestazione:
-1.73%
6M Prestazione:
-5.38%
1 anno Prestazione:
+13.19%
Intervallo 1D:
$125.20
$129.64
Intervallo di 1 settimana:
$120.70
$129.64
Portata 52W:
$110.86
$140.84
Abbott Laboratories Stock (ABT) Company Profile
Nome
Abbott Laboratories
Settore
Industria
Telefono
(224) 667-6100
Indirizzo
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Confronta ABT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
128.41 | 218.16B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
91.97 | 137.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.54 | 135.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.50 | 128.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.61 | 48.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-10 | Iniziato | The Benchmark Company | Buy |
| 2025-07-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-06-16 | Iniziato | Leerink Partners | Market Perform |
| 2024-10-08 | Iniziato | Oppenheimer | Outperform |
| 2024-09-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Downgrade | Edward Jones | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-21 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Reiterato | Barclays | Overweight |
| 2023-04-20 | Reiterato | Bernstein | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Raymond James | Outperform |
| 2023-04-20 | Reiterato | UBS | Buy |
| 2023-04-20 | Reiterato | Wolfe Research | Underperform |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-27 | Reiterato | Credit Suisse | Outperform |
| 2022-01-27 | Reiterato | Morgan Stanley | Overweight |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-27 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-01-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-06-01 | Downgrade | Goldman | Neutral → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-02-07 | Reiterato | BofA/Merrill | Buy |
| 2019-01-02 | Downgrade | Citigroup | Neutral → Sell |
| 2018-11-30 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-01-30 | Reiterato | Citigroup | Neutral |
| 2018-01-25 | Reiterato | Stifel | Buy |
| 2018-01-25 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-10-19 | Reiterato | Stifel | Buy |
Mostra tutto
Abbott Laboratories Borsa (ABT) Ultime notizie
Global Interventional Cardiology Devices Market is Predicted to Cross ~USD 30 Billion by 2034, Due to the Rising Cardiovascular Disease Burden | DelveInsight - GlobeNewswire Inc.
Gastrointestinal Diagnostics (GI) Market to Reach $5.8 Billion by 2030 - GlobeNewswire Inc.
Abbott Gains From Lingo CGM's Expansion on Android Platform - TradingView — Track All Markets
Rep. Julie Johnson Sells Abbott Laboratories (NYSE:ABT) Stock - MarketBeat
Texas Permanent School Fund Corp Sells 65,976 Shares of Abbott Laboratories $ABT - MarketBeat
Stance Capital LLC Makes New $1.30 Million Investment in Abbott Laboratories $ABT - MarketBeat
Prostate Cancer Diagnostics Market Is Going to Boom |• Abbott • Siemens - openPR.com
Corient Private Wealth LLC Increases Holdings in Abbott Laboratories $ABT - MarketBeat
Caldwell Trust Co Takes Position in Abbott Laboratories $ABT - MarketBeat
17,830 Shares in Abbott Laboratories $ABT Bought by B. Riley Wealth Advisors Inc. - MarketBeat
Abbott Laboratories Strengthens Shareholder Returns Amid Strategic Acquisition - AD HOC NEWS
Abbott Laboratories (ABT) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025 - ts2.tech
Westwood Holdings Group Inc. Reduces Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by Provident Investment Management Inc. - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Public Sector Pension Investment Board - MarketBeat
Key facts: Abbott Laboratories appoints Nita Ahuja to Board; VP reports share gift - TradingView — Track All Markets
Elevatus Welath Management Boosts Position in Abbott Laboratories $ABT - MarketBeat
Does Abbott Laboratories (NYSE:ABT) Have A Healthy Balance Sheet? - Yahoo Finance
Curi Capital LLC Acquires 53,244 Shares of Abbott Laboratories $ABT - MarketBeat
Benjamin Edwards Inc. Has $45.44 Million Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat
Ameriprise Financial Inc. Grows Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stake Boosted by Adage Capital Partners GP L.L.C. - MarketBeat
Abbott Laboratories (ABT) Expands Board of Directors with New Ap - GuruFocus
Abbott Laboratories Expands Board with New Appointment - TipRanks
Abbott Laboratories (ABT) Stock: Dividend Boost and Major Acquisition Drive 2026 Outlook - CoinCentral
Abbott Laboratories (ABT) Boosts Quarterly Dividend by 6.8% - GuruFocus
Abbott Laboratories Declares 408th Consecutive Quarterly Cash Common Dividend, Payable on February 13, 2026 - marketscreener.com
Abbott (ABT) Raises Quarterly Dividend by 6.8% - GuruFocus
Abbott Raises Quarterly Dividend to $0.63 a Share, Payable Feb. 13 to Holders of Record as of Jan. 15 - marketscreener.com
Abbott increases quarterly dividend by 6.8% for 54th consecutive year - Investing.com
Abbott increases quarterly dividend for 54th consecutive year - PR Newswire
Abbott Laboratories (ABT) Receives a Buy from Citi - The Globe and Mail
Abbott Laboratories price tries to recoup some lossesForecast today12-12-2025 - Economies.com
Quantinno Capital Management LP Purchases 113,751 Shares of Abbott Laboratories $ABT - MarketBeat
Assessing Abbott (ABT) Valuation After New Lingo CGM Expansion and Protein-Glucose Data Release - simplywall.st
Peapack Gladstone Financial Corp Buys 23,212 Shares of Abbott Laboratories $ABT - MarketBeat
Ieq Capital LLC Acquires 28,181 Shares of Abbott Laboratories $ABT - MarketBeat
Laird Norton Wetherby Trust Company LLC Has $7.36 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Life Experiences Shape Our Work - Abbott
Technology that connects you to what matters most: Your health - Abbott
Alliancebernstein L.P. Sells 168,803 Shares of Abbott Laboratories $ABT - MarketBeat
Doing more for children’s health around the world - Abbott
Abbott Presses Congress for Shield Over Preemie Baby Formula Litigation That Could Cost It Billions - Claims Journal
Abbott Announces Its New Specialty and Metabolic Powder Nutritional Manufacturing Facility Will Be in Bowling Green, Ohio - Abbott
The Abbott World Marathon Majors - Abbott
Our People And Culture - Abbott
Responsibility - Abbott
Sustainability - Abbott
Abbott Fund - Abbott
Diagnostics Testing - Abbott
Abbott Laboratories Azioni (ABT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.77%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):